A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

Publisher： Karger

E-ISSN： 1664-5464|3|1|459-467

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.3, Iss.1, 2013-12, pp. : 459-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Antidepressant Treatment with Moclobemide for Aphasia in Acute Stroke Patients: A Randomised, Double-Blind, Placebo-Controlled Study

By  

Cerebrovascular Diseases, Vol. 19, Iss. 2, 2005-02 ,pp. : 125-132

Karger

Access to resources Recommend Favorite

Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial

By Bell Robert   Rear Roger   Cunningham John   Dawnay Anne   Yellon Derek  

Clinical Research in Cardiology, Vol. 103, Iss. 3, 2014-03 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite

Fluoxetine Is Not Effective in the Treatment of Poststroke Fatigue: A Double-Blind, Placebo-Controlled Study

By  

Cerebrovascular Diseases, Vol. 23, Iss. 2-3, 2006-11 ,pp. : 103-108

Karger

Access to resources Recommend Favorite

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke

By  

Cerebrovascular Diseases, Vol. 12, Iss. 3, 2001-10 ,pp. : 253-257

Karger

Access to resources Recommend Favorite